Clinical trial
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
NCT03108885 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Terminated
- Start date
- October 1, 2017
- Completion date
- May 25, 2020
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer of esophagus, cancer of the esophagus, esophageal cancer, esophageal neoplasm, esophageal neoplasms malignancy unspecified, esophageal neoplasms malignant, esophagus cancer, neoplasm, esophageal